PARTICIPATING COMPANIES

Companies participating at Biotech Showcase 2023

 
United States

1859

 
United States

1910 Genetics

 
United States

1cBio

 
United States

20/20 GeneSystems, Inc.

 
 
United States

203 Investment Partners

 
United States

280 Bio, Inc.

 
Australia

360biolabs

 
 
Monaco

3B Future Health Ventures

 
 
United States

3CC

 
 
United States

3E Bioventures

 
Iceland

3Z

 
 
United Kingdom

4BIO Capital

 
United States

4M Therapeutics Inc.

 
France

4P -Pharma

 
United States

5AM Ventures

 
 
United States

6 Dimensions Capital

 
United States

64x Bio

 
 
United States

7G BioVentures, LLP

 
Singapore

A*STAR

 
Austria

a:head bio AG

 
United States

Aagami, Inc.

 
United States

Aardvark Therapeutics

 
Sweden

Abarceo Pharma AB

 
China

Abbott

 
 
United States

ABES Partmers

 
 
United States

Abingworth

 
United States

Abintus Bio, Inc.

 
South Korea

Abion

 
 
United States

Abry Partners

 
South Korea

AbTis

 
United States

Academy of Managed Care Pharmacy (AMCP)

 
 
United States

Accelerate Blue

 
 
Sweden

Accequa AB

 
United States

Access Bio, Inc.

 
United States

Access Life Sciences

 
United States

Access Vascular, Inc.

 
Australia

Acclime Australia

 
United States

AccuraGen

 
United States

Acelot

 
United States

Achelios Therapeutics

 
United States

Achelois BioPharma

 
United States

Aclipse Therapeutics

 
United States

Acoustic Bio Inc.

 
 
United States

ACS BrightEdge

 
France

Acticor Biotech

 
United Kingdom

Actimed Therapeutics

 
United States

Actinium Pharmaceuticals

 
United States

Action Potential Venture Capital (GSK)

 
United States

Actipulse Neuroscience

 
United States

Activate Therapeutics

 
Australia

AcuraBio

 
 
United States

Acuris Partners

 
United States

Adagene

 
Australia

Adalta Ltd

 
United States

Adanate

 
 
United States

Adaptive Capital Management Partners, LLC

 
United States

Adaptive Research

 
Australia

Adherium, Inc.

 
 
United States

AdimaBio Ventures

 
United States

adiso therapeutics

 
 
United States

Adjuvant Capital

 
United States

Adjuvant Partners

 
 
Canada

adMare BioInnovations

 
France

ADOCIA

 
United States

Adora Life Science

 
Germany

Adrenomed AG

 
United States

ADRx, Inc.

 
United States

AdvaMed

 
 
United States

Advent Capital Management

 
United States

Aegle Therapeutics Corp

 
Belgium

Aelin Therapeutics NV

 
United States

Aeolian Biotech

 
United States

Aerami Therapeutics

 
United States

AffaMed Therapeutics Inc.

 
France

AFFILOGIC

 
 
United States

Affinity Asset Advisors

 
South Korea

AffyXell Therapeutics

 
 
Japan

Aflac Ventures Japan

 
Denmark

AFYX Therapeutics

 
United States

AGC Biologics

 
 
United States

age1 Fund I GP, LLC

 
United States

Agenus Inc.

 
France

AGILE CAPITAL MARKETS

 
 
United States

Agilent - Early Stage Partnerships

 
Australia

Agilex Biolabs

 
 
Netherlands

Aglaia Oncology Funds

 
Spain

AHEAD THERAPEUTICS SL

 
 
United States

AIAC Group

 
 
Canada

AIC Global Holdings

 
Germany

AiCuris Anti -infective Cures AG

 
United States

Aikium

 
United States

AIM Biotech

 
South Korea

Aimed Bio Inc.

 
 
United States

Aisling Capital

 
United States

AIVITA Biomedical, Inc.

 
Japan

Ajinomoto Co., Inc

 
Japan

Ajinomoto Co., Inc. Corporate Venture Capital

 
United States

Akadeum Life Sciences, Inc.

 
United Kingdom

Akari Therapeutics plc

 
United States

akelos inc

 
United States

Akili, Inc

 
 
United Kingdom

Albion Capital

 
France

ALCEDIAG

 
United States

Algen

 
Hong Kong, S.A.R.

ALiA BioTech Holdings Limited

 
 
United States

Alignment Ventures

 
United States

Alira Health

 
United States

Alix Ventures

 
United States

Allele Capital Partners

 
United States

Allergenis

 
United States

Alliance for Regenerative Medicine

 
 
United States

AllianceBernstein

 
 
Canada

AllosteRx Capital

 
United States

Alloy Therapeutics

 
United States

Alora Pharmaceuticals

 
United States

Alpenglow Biosciences

 
Israel

Alpha Tau Medical Ltd.

 
United States

Alphageneron Pharmaceuticals, Inc.

 
United States

AlphaSense

 
 
United Kingdom

ALSA Ventures

 
 
United States

Alta Ventures

 
United States

Altoida

 
United States

AltruBio, Inc.

 
Canada

Altus Formulation Inc.

 
United States

Aluda Pharmaceuticals

 
 
United States

Alumni Ventures

 
United States

Alvea

 
United States

Alveolus Bio

 
Canada

AmacaThera Inc.

 
United States

Amaro Therapeutics, Inc.

 
United States

Amberstone Biosciences Inc

 
United States

Ambrx Biopharma Inc.

 
United States

AMD Therapeutics LLC

 
 
Canada

Ameretat Investment Ltd.

 
 
United States

Ames Ventures LLC

 
United States

Amplicore Inc.

 
United States

Amplo Biotechnology

 
South Korea

AmtixBio Co., Ltd.

 
Belgium

AMYL THERAPEUTICS

 
 
United States

Amzak Capital Management

 
 
France

Andera partners

 
 
United States

Andreessen Horowitz

 
Canada

Angany inc.

 
 
United States

Angel investor - Harneet Bath

 
 
United States

Angels + Life.Sci Investors NJAngels.net

 
United States

Anima Biotech

 
United States

Anixa Biosciences, Inc.

 
United States

Annpo Biotechnology, Inc.

 
France

ANTABIO SAS

 
Denmark

Antag Therapeutics

 
 
United States

Anthro Ventures

 
Australia

Antisense Therapeutics Limited

 
United Kingdom

Antiverse

 
 
United States

Anzu Partners

 
Belgium

Apaxen

 
 
United Kingdom

Apeiron Investment Group

 
United States

Aperture Therapeutics, Inc.

 
United Kingdom

Apex Healthcare Consulting Limited

 
United States

Aplife Biotech Corporation

 
 
United States

Apollo Health Ventures

 
Israel

Aposense

 
France

Apparius Corporate Finance

 
United States

Aptose Biosciences

 
United States

Aqua Partners LLC

 
United States

Aqualung Therapeutics, Corp

 
United States

Aquyre Biosciences

 
United States

Aralez Inc.

 
South Korea

Arbormed Co., Ltd

 
United Kingdom

Arc Bio Communications

 
 
United States

ARCH

 
United Kingdom

Arctoris

 
Belgium

Ardena

 
 
United States

Arena Investors

 
 
France

ArgoBio Studio

 
United States

Aria Pharmaceuticals

 
United States

Arialys Therapeutics

 
United States

Arima Genomics Inc

 
United States

Aristea Therapeutics

 
United States

Arizona Bioindustry Association, Inc. (AZBio)

 
United States

Arizona State University

 
United States

Arog Pharmaceuticals, Inc.

 
Australia

Arovella Therapeutics

 
United States

ARSENAL Life Science

 
 
United States

Artiman Ventures

 
United States

ArtiMed Inc.

 
 
Spain

Asabys Partners

 
Japan

Asahi Kasei Corporation

 
 
United States

Asahi Kasei Ventures

 
United Kingdom

Ascend Gene & Cell Therapies

 
United States

Ascendia Pharmaceuticals, Inc.

 
 
United States

Ascendiant Capital

 
United States

Ascento Medical

 
United States

ASDERA LLC

 
United States

Ash Ingredients, Inc.

 
United States

Ashvattha Therapeutics, Inc

 
 
France

ASKLEPIOS ADVISORS

 
Canada

Aspect Biosystems

 
United States

Aspen Biosciences

 
United States

AssayQuant Technologies, Inc.

 
United States

Astellas Pharma Inc

 
 
United States

Astellas Rx + Business Accelerator LLC

 
 
United States

Astellas Venture Management LLC

 
 
United States

Astia

 
Belgium

AstriVax NV

 
Belgium

atb therapeutics

 
 
United States

ATEM Capital

 
 
United States

Athena Bioventures

 
 
United States

Atheneos Ventures

 
United States

Athos Therapeutics, Inc.

 
 
United States

ATMAN LIMITED PARTNERS

 
Australia

Atmo Biosciences Ltd

 
Germany

Atriva Therapeutics GmbH

 
United States

Attivare Therapeutics

 
United States

aTyr Pharma

 
Australia

Aucentra Therapuetics

 
United Kingdom

Audax Therapeutics

 
Singapore

AUM Biosciences Pte Ltd

 
Israel

Aummune

 
 
United Kingdom

Aurea Holdings Limited

 
 
Italy

AurorA Science s.r.l.

 
United States

AustinPx

 
United States

Autonomous Therapeutics, Inc.

 
United States

Avalo Therapeutics, Inc.

 
United States

Avammune Therapeutics Inc.

 
United States

Avance Clinical, LLC

 
Netherlands

Avanzanite Bioscience BV

 
United States

Avcentx Therapeutics Inc

 
Ireland

Avectas

 
 
United States

Avenue Capital Group

 
United States

Avidity Biosciences

 
United States

Avistone Biotechnology Co., Inc.

 
United States

Avstera Therapeutics Corp.

 
 
Switzerland

Awen GmbH

 
 
United Kingdom

AXA IM

 
 
Japan

Axil Capital Advisors

 
Canada

Axiom Real -Time Metrics

 
United States

AyuVis Research, Inc.

 
United States

Azora Therapeutics Inc

 
United States

Bachem

 
 
United Kingdom

Backed VC

 
United States

BairesDev LLC

 
Thailand

Baiya Phytopharm

 
United States

BAKX Therapeutics

 
 
United States

Band of Angels

 
United States

Bantam Pharmaceutical

 
United Kingdom

Barrington James

 
Germany

baseclick GmbH

 
United Kingdom

Baseimmune

 
United States

Bask Health

 
China

Bayer Pharmaceuticals

 
 
United States

BayMed Venture Partners

 
Switzerland

BC Platforms

 
United States

BCN Biosciences

 
 
Canada

BDC CAPITAL

 
 
Taiwan, China

BE Health Ventures

 
United States

BehaVR

 
China

BeijingWeiyeMetrologyandTechnologyResearchInstitutionCo.,Ltd

 
Canada

Bellus Health

 
 
United States

Benchmark Company

 
 
United States

Berenberg

 
 
United States

Bering Capital

 
 
United States

Berkeley Frontier Fund

 
United States

Bespoke Biotherapeutics

 
United States

Bexion Pharmaceuticals, Inc.

 
Australia

Beyond Drug Development

 
United States

Big4Bio

 
 
South Korea

Bigbang Angels, Ltd.

 
United States

Bilayer Therapeutics, Inc.

 
United States

Bill and Melinda Gates Foundation

 
 
United States

BIMA Capital

 
 
Canada

Bio Ideations

 
Canada

Bio -stream Diagnostics Inc

 
Turkey

Bio -T Biotechnology

 
United States

BioBuzz Media

 
 
Australia

BioCapital Impact Fund Pty Ltd

 
Brazil

BIOCARE | SPARKIA - Innovation & Healthcare

 
United States

BioCentury

 
Australia

BioCina Pty Ltd

 
 
United States

Biocoast Capital

 
United States

Biocom California

 
France

Biocorp

 
United States

Biocytogen Pharmaceuticals (Beijing) Co., Ltd.

 
France

BIODENA CARE

 
United States

BioDirectors, LLC

 
United States

BioDuro -Sundia

 
United States

BioEclipse Therapeutics

 
 
Taiwan, China

BioEngine Capital (legal name: BioEngine Technology Development Inc.)

 
United Kingdom

Biofidelity Ltd

 
Germany

BioFlux Group

 
United States

Biogen

 
 
Netherlands

BioGeneration Ventures

 
Sweden

BioInvent International AB

 
Israel

BioLIneRx Ltd.

 
United States

BioLinkUp, LLC

 
United States

Biolocity at Georgia Tech and Emory University

 
 
United States

BioMap

 
 
Israel

Biomed Options Ltd.

 
United States

Biomedical Advanced Research and Development Authority (BARDA)

 
South Korea

BioMetrix Technology, Inc

 
Israel

BiondVax Pharmaceuticals Ltd

 
France

BIONEST PARTNERS FINANCE

 
United States

BioNJ

 
United Kingdom

BioPartner UK

 
United States

BioPharma Dive

 
 
Belgium

Bioqube Ventures

 
 
United States

BioRock Ventures Management Co., LLC

 
 
United States

Bios Partners

 
 
Australia

Bioscience Equity Partners

 
Australia

Bioscience Managers Pty Ltd

 
United States

BioscienceLA

 
United States

Biosion USA, Inc.

 
United States

Biosortia Microbiomics

 
United States

BioSymetrics

 
Canada

BIOTECanada

 
 
Netherlands

Biotech Mountains BV

 
United States

BIOTECH THERAPEUTICS

 
United States

BiotechExec

 
Switzerland

Biotechgate

 
United States

BioTools Innovator

 
 
United States

Bioverge

 
Switzerland

BioVersys AG

 
Sweden

Biovica International AB

 
 
Luxembourg

Biovision Ventures

 
Belgium

BIOXODES SA

 
United States

Bioxytran Inc.

 
United States

Bisnow

 
Japan

bitBiome, Inc.

 
 
United States

BL/SH Financial

 
 
United States

Black Opal Ventures

 
Brazil

BLANVER

 
United States

Bloom Science

 
United States

Bloomberg

 
 
United States

Blue Goose Capital LLC

 
United States

Blue Matter Consulting

 
United States

Blue Water Vaccines Inc.

 
 
South Korea

Bluepoint Partners

 
Austria

BlueSky Immunotherapies

 
 
United States

Bluestar Investment Managers, SA

 
South Korea

BNC Korea Co.,Ltd.

 
United States

Body Vision Medical

 
 
China

BOHE ANGEL

 
United States

Bond Biosciences, Inc.

 
 
United States

borex capital

 
South Korea

Boryung Co., LTD.

 
United States

Boston Globe

 
 
United States

Boston Harbor Angels

 
United States

Boston Oncology

 
 
United States

Bowen Inc

 
 
United States

BoxOne Ventures

 
 
Hong Kong, S.A.R.

Boyu Capital

 
 
France

Bpifrance - innobio

 
 
United States

Brace Pharma Capital

 
United States

BRAiN

 
United States

Brainify.AI

 
United States

Brainstorm Cell Therapeutics

 
 
Australia

Brandon Capital (Brandon BioCatalyst)

 
 
United States

Brazen Capital, LLC

 
Canada

Breathe BioMedical

 
France

Brenus Pharma

 
South Korea

BREXOGEN INC

 
United States

BriaCell Therapeutics Corp.

 
United States

Bridge - your iCCO company

 
South Korea

Bridge Biotherapeutics, Inc

 
United States

Bridge Builders Collaborative

 
United States

BridgeBio

 
United States

BridGene Biosciences

 
Canada

BriGene Biosciences Inc.

 
Japan

BrightPath Biotherapeutics

 
United States

Brinter Inc

 
 
United States

BroadOak Capital Partners

 
 
United States

Broadview Ventures

 
 
United States

Brookline Capital Markets

 
United States

Bryleos

 
 
United States

BTIG

 
 
United States

Builders VC

 
United States

Buto Corporation

 
 
United States

Button Capital

 
 
China

BVCF

 
 
United States

BVE

 
United States

C14 Consulting Group

 
Japan

C4U Corporation

 
 
United States

CaaS Capital Management

 
 
Canada

CABHI Ventures

 
United States

Cadrenal Therapeutics, Inc.

 
United States

Caeregen Therapeutics, LLC

 
United States

California Life Sciences

 
United States

California Life Sciences Association

 
 
United States

Camber Road Partners

 
United States

Cambrian BioPharma

 
United Kingdom

Cambridge Nucleomics

 
 
United States

Camford Capital

 
Israel

Can -Fite BioPharma

 
United States

Cancer Research Institute

 
United States

CancerFree Biotech

 
 
United States

Cantilever Investors

 
 
United States

Cantos

 
 
United States

Capital One Securities

 
Germany

Captain T Cell

 
Poland

Captor Therapeutics S.A.

 
United States

Caren Pharma

 
Australia

Carina Biotech

 
United States

Carmine Therapeutics, Inc.

 
 
Sweden

Carnegie

 
United Kingdom

Carocell Bio

 
Australia

Cartherics Pty Ltd

 
United Kingdom

Case45

 
United States

Casey Insights

 
 
United States

Cassel Salpeter, LLC

 
United States

Castor

 
Lithuania

Caszyme

 
United States

Catalyst Clinical Research

 
United States

Catalyst Health Care Consulting

 
 
Israel

Catalyst Investments

 
 
United States

Catalytic Impact Foundation

 
 
United States

Catalyze Dallas

 
 
United States

Cathay Health

 
 
United States

CAV Angels

 
United States

Cayuga Biotech

 
 
United States

CBC Group

 
United States

CBRE

 
South Korea

Cdmogen Co., Ltd.

 
 
United States

Cedars -Sinai Health System - Accelerator

 
Canada

Cedience

 
United States

Celine Therapeutics

 
United Kingdom

Cell and Gene Therapy Catapult

 
United States

Cell Harbor

 
United States

Cell Source, Inc.

 
United States

Cell X Technologies, Inc

 
United States

CellAI

 
United States

Cellectar Biosciences

 
United States

Cellino

 
United States

Cellphire Therapeutics, Inc.

 
Italy

Cellply Srl

 
United States

CellVax Therapeutics

 
Canada

Cerebra Medical

 
United States

Cerner Enviza / Oracle

 
United States

Certara

 
United States

Certified Genetool Inc.

 
United States

CG Life

 
United States

CG Pharmaceuticals, Inc.

 
South Korea

CHA BIO GROUP

 
United States

Chameleon Biosciences

 
United States

Charles River Laboratories

 
United States

Charles River Labs Insourcing Solutions

 
Switzerland

CheckOrphan

 
United States

Chemical & Engineering News

 
 
United States

Chemical Angel Network

 
India

Chemveda Life Sciences

 
 
United States

Chiesi Ventures

 
United States

Chiima Therapeutics

 
 
United States

Children's Healthcare of Atlanta

 
Canada

Chimeric Therapeutics Limited

 
 
China

China Everbright Limited

 
Japan

Chiome Bioscience

 
Denmark

Chosa

 
United States

Chronic Airway Therapeutics, Inc.

 
United States

Chrysalis BioTherapeutics, Inc.

 
Netherlands

CiMaas

 
United States

Cincinnati Children's Hospital

 
 
United States

CincyTech

 
United States

Cipla

 
Sweden

Circio AB

 
United States

Cision Vision

 
Canada

Citeline

 
 
United States

Claremont Creek Ventures

 
 
Italy

Claris Ventures SGR S.p.A.

 
United States

Clarix Imaging

 
 
United States

Class Bravo Ventures

 
United States

Clayton Biotechnologies, Inc.

 
Norway

ClexBio

 
Switzerland

Clinerion

 
 
United States

Clinical Research Ventures

 
United States

Close Concerns

 
Canada

Cloud DX

 
United States

Cloud Thoughts Consulting

 
Australia

CMAX Clinical Research Pty Ltd

 
Japan

CMIC HOLDINGS Co., Ltd.

 
 
United Kingdom

CMS Ventures

 
United States

Coagulation Sciences

 
 
Norway

Coalition for Epidemic Preparedness Innovations

 
 
United States

Cobro Ventures

 
United States

Cocrystal Pharma

 
 
United States

Codon Capital

 
Sweden

Coegin Pharma AB

 
United States

Coeurative, Inc.

 
United States

Cogmotos, Inc.

 
United States

Cognesy Therapeutics

 
United States

CogniFit Inc

 
United States

Cognition Therapeutics

 
United States

Cognito Therapeutics, Inc.

 
Switzerland

Cohesion Bureau

 
 
United States

Coho Deeptech

 
United States

Combined Therapeutics

 
United States

Comera Life Sciences Holdings, Inc.

 
United States

Compass Pathways

 
United States

Complete Genomics

 
 
United States

Compound

 
United States

Comprehensive Cell Solutions/NYBC

 
United States

Concarlo Therapeutics Inc.

 
Canada

Congruence Therapeutics

 
United States

Connect Biopharma

 
 
United States

Connecticut Innovations, Inc.

 
 
United States

Conscience

 
United States

Consulate General of Canada

 
United States

Content Carnivores, LLC

 
 
United States

Continuum Health Ventures

 
 
Switzerland

Convergence Partners AG

 
 
Norway

coremed

 
Japan

CoreTissue BioEngineering Inc.

 
United States

Corstasis Therapeutics

 
 
United States

Cortado Ventures

 
 
Japan

Corundum Systems Biology

 
Switzerland

Coulter Partners

 
 
United States

Cove Fund

 
United States

Covington & Burling LLP

 
United States

CovInnovations

 
Japan

Craif Inc.

 
United Kingdom

Cranfield University

 
United States

Createrna USA, Inc.

 
United States

Creative Ventures

 
United States

CRISP -HR Therapeutics

 
United States

CRISPR QC

 
United States

CRISPR Therapeutics

 
 
Canada

Cross -Border Ventures

 
United States

Crosswave Management

 
United States

CRV

 
United States

Cryoport Systems

 
United States

CTI Biopharma

 
 
Canada

CTI Life Sciences

 
United States

Cullgen Inc.

 
 
United States

Cura Capital

 
United States

Cura Therapeutics

 
South Korea

Curacle

 
United States

Curate Biosciences

 
United States

CureLab Oncology and/or CureLab Veterinary

 
United States

CureMeta

 
Israel

CURESPONSE LTD

 
United States

Curevo Vaccine

 
United States

Curi Bio, Inc.

 
United States

Curia

 
 
United States

Curie.Bio

 
United States

Cyclacel Pharmaceuticals, Inc.

 
United States

Cyclo Therapeutics, Inc.

 
United States

CyMeda, Inc

 
United States

Cyrano Therapeutics, Inc.

 
South Korea

Cyrus Therapeutics

 
Japan

CyTIX Inc.

 
United States

CytoAgents, Inc

 
United States

Cytonus Therapeutics Inc

 
United States

CytoSite Biopharma.com

 
Norway

Cytovation ASA

 
United States

Cytovia Therapeutics Inc

 
Sweden

Cyxone AB

 
South Korea

Daewoong Pharmaceutical Co., Ltd

 
Canada

Dalriada Drug Discovery

 
 
South Korea

DAOL Investment

 
United States

Data Driven Bioscience

 
 
United States

Data Expanse Ventures & Berkeley Angel Network

 
 
United States

David Fox Syndicate

 
 
United States

Dawson James

 
 
South Korea

DAYLI partners

 
 
United States

DCVC Bio

 
Australia

De Motu Cordis

 
 
United Kingdom

Debere capital partners

 
 
Switzerland

Debiopharm Innovation Fund SA

 
 
United States

Decheng Capital

 
United States

DeckTherapeutics Inc

 
Canada

Deep Genomics

 
 
United States

Deep Views Inc.

 
United States

DeepCure

 
 
United States

Deerfield

 
 
United States

DEFTA Partners

 
United States

Deka Biosciences

 
 
China

Delian Capital

 
 
Switzerland

Delin Venture Partners

 
 
Hong Kong, S.A.R.

Delos Capital

 
United States

Delpor, Inc.

 
United States

Dermaliq Therapeutics, Inc.

 
United Kingdom

Destiny Pharma plc

 
 
United States

DFB Pharmaceuticals

 
 
Japan

DG Daiwa Ventures

 
France

Diaccurate

 
United States

Diadem Biotherapeutics

 
 
Taiwan, China

Diamond Biofund Inc.

 
 
United States

Diamond Edge Ventures

 
 
United States

digitx partners

 
United States

Dimension Genomics Inc

 
United States

Dionysus Digital Health, Inc

 
United States

Diorasis Therapeutics

 
United States

Dipharma Inc.

 
 
United States

Divergent Capital

 
United States

Diviner

 
United States

DNA Analytics

 
Canada

Domain Therapeutics NA Inc.

 
United States

Dorian Therarapeutics

 
 
United States

Dorset Capital LLC

 
Denmark

Draupnir Bio

 
United States

Drexel University

 
 
United States

Duce Management, LLC.

 
United States

Duet BioTherapeutics

 
 
United States

Dynamk Capital

 
Japan

e -Projection K.K.

 
Japan

EA Pharma Co., Ltd.

 
 
Germany

Earlybird Venture Capital

 
United States

EarlyDiagnostics

 
 
United States

Easton Capital Investment Group

 
 
United States

Echo Investment Capital

 
Singapore

EDDC

 
United Kingdom

Edingurgh Molecular Imaging

 
United Kingdom

Edison Group

 
Japan

EditForce, Inc.

 
 
United States

EF Hutton

 
 
Puerto Rico

EGB Ventures

 
France

Egle Therapeutics

 
 
Japan

Eight Roads Ventures

 
China

Eisai China

 
 
United States

Eisai Co., Ltd.

 
 
United States

Eisai Innovation Inc

 
United States

eisnerAmper

 
United Kingdom

Elasmogen Ptd

 
United States

Elastrin Therapeutics Inc.

 
 
United States

Elevate Ventures

 
United States

Elevian, Inc.

 
United States

Elex Biotech

 
France

Eligo Bioscience

 
Taiwan, China

Elixiron Immunotherapeutics

 
United Kingdom

Ellipses Pharma Ltd

 
Belgium

ElmediX NV

 
United States

Elpis Biopharmaceuticals

 
China

Elpiscience Biopharma

 
 
United States

Embark Ventures

 
 
United States

EMCI Fund

 
United States

EMD Serono / Merck KGaA, Darmstadt, Germany

 
 
United States

Emerald Bioventures, LLC

 
United States

Emergent

 
United States

Emory University

 
United States

EMPIRI, Inc.

 
Australia

Emyria

 
 
United States

Endeavor Life Sciences

 
 
Switzerland

Endeavour Vision

 
United States

Endometrics

 
United States

Endpoints News

 
United States

Endure Biotherapeutics, Inc.

 
United Kingdom

Enhanc3D Genomics

 
United States

Entac Medical

 
United States

Entelexo Biotherapeutics

 
United Kingdom

EnteroBiotix

 
Singapore

Enterprise Singapore

 
United States

Enthorin Therapeutics

 
United States

Enveric Biosciences

 
United States

Envisagenics

 
United States

EnZen Therapeutics, Inc.

 
India

Enzene Biosciences Limited

 
United States

Enzyme by Design Inc

 
 
United States

EO Ventures

 
United States

Eolo Pharma

 
 
United States

Eos BioInnovation

 
Australia

EpiAxis Therapeutics

 
Belgium

Epics Therapeutics

 
 
United Kingdom

Epidarex Capital

 
France

Epigene Labs

 
 
United States

Equitos Venture Partners

 
 
United States

Eric Anschutz

 
Ireland

ERS Genomics

 
Switzerland

EsoCap AG

 
United Kingdom

ESP Diagnostics Limited

 
 
United Kingdom

Esperante

 
United States

Estrato Pharma Inc

 
United Kingdom

Etcembly

 
South Korea

EuBiologics Co., Ltd.

 
United States

Evaluate

 
India

Eventible

 
South Korea

EverEx

 
 
United States

Evexia BioFund

 
United Kingdom

Evgen Pharma plc

 
 
Sweden

EVM AB

 
United States

Evoke Canale

 
United States

EVOLUTION Life Science Partners

 
United States

Evotec

 
United Kingdom

Evox Therapeutics Limited

 
 
Singapore

EVX Ventures

 
United States

ExcepGen

 
United States

Excision

 
United States

Exner Incorporated

 
Denmark

ExpreS2ion Biotech Holding AB

 
Canada

Eyam Vaccines and Immunotherapeutics

 
Austria

F2G Ltd

 
United Kingdom

FabRx

 
Canada

FACIT

 
 
Israel

Family Office

 
Finland

Faron Pharmaceuticals

 
 
Singapore

Farquhar VC

 
 
United States

Fast Track Initiative, Inc.

 
 
United States

FC Capital Management

 
Canada

Feldan Therapeutics

 
United States

Felicitex Therapeutics, Inc.

 
 
United States

FemHealth Ventures

 
United States

Ferring

 
Germany

FGK Clinical Research GmbH

 
Canada

Fibrocor Therapeutics Inc.

 
United States

Fierce Biotech

 
United States

Filtricine, Inc.

 
 
United States

Finney Capital

 
United States

Firalis S.A

 
United States

First Ascent Biomedical

 
Sweden

Flow Neuroscience

 
 
United States

Flu Lab

 
United States

FluidForm

 
United States

Fluxus, Inc.

 
United States

Foley Hoag LLP

 
 
United States

Foothill Ventures

 
 
Netherlands

Forbion

 
 
United States

FORCE Family Office

 
United States

Forcyte Biotechnologies, Inc

 
 
United States

Foresite Capital

 
United States

Formic Labs

 
 
United States

Fortunatus Capital

 
 
China

Fortune Capital

 
 
Switzerland

Forty51 Ventures

 
 
United States

Forward Equity Partners Corp.

 
 
United States

FOS Capital Partners

 
Switzerland

Fosun Pharmaceutical AG

 
United States

FoundersX Ventures

 
 
United States

Fountain Healthcare Partners

 
 
United States

Frazier Life Sciences

 
United States

Freelance Journalist

 
 
United States

FreeMind Investments

 
United States

FUJIFILM Cellular Dynamics

 
United States

FujiFilm Irvine Scientific

 
United States

FUJIFILM Wako Chemicals USA

 
Japan

FunPep Co., Ltd.

 
 
United States

Fusion Fund

 
Israel

Futurx

 
United States

Fzata, Inc.

 
United States

Gain Therapeutics

 
Canada

Gandeeva Therapeutics

 
United States

Gather Labs

 
United States

GBI Bio

 
South Korea

GC Biopharma

 
 
United States

GCF Family Office

 
 
United States

GEM NY

 
 
Japan

Gemseki Ventures LP

 
United States

GEn1E Lifesciences Inc.

 
United States

GeneCopoeia, Inc

 
United States

GeneOnline US INC

 
United States

GeneScience Pharmaceutical Co., Ltd

 
Italy

Genespire

 
 
Canada

Genesys Capital

 
United States

Genetic Engineering & Biotechnology News

 
United States

GeneToBe Inc

 
United States

Genezen

 
France

GENFIT SA

 
United States

Genome Insight

 
South Korea

GenomeOpinion

 
United States

GenScript USA Inc

 
China

Gentas Biotechnology

 
United States

George Clinical

 
United States

GeoVax Labs, Inc.

 
 
Hong Kong, S.A.R.

GF Investments (Hong Kong) Company Limited

 
France

GIE Eurasante

 
United States

GigaMune

 
United States

Gila Therapeutics

 
Israel

Gilboa Therapeutics

 
 
Netherlands

Gilde Healthcare

 
United States

Gilead Sciences

 
 
Belgium

Gimv

 
United States

Ginkgo Bioworks

 
France

GIP GENOPOLE

 
 
United States

Global Alpha Ventures

 
United States

Global Alzheimer's Platform Foundation

 
 
United States

Global BioAccess Fund

 
 
Japan

Global Brain

 
United States

Global Consortium for Reproductive Longevity & Equality; Buck Institute for Research on Aging

 
 
United States

Global Emerging Markets Group

 
 
United States

Global Health Impact Fund

 
 
United States

Global Health Investment Corporation

 
Australia

Global Plus Diagnostics

 
 
United States

Global X Funds

 
Canada

GlobalConnectworks Ltd.

 
United States

GlobalData Pharma

 
United States

GlycoEra

 
 
Switzerland

GOGOL ASSOCIATES

 
 
United States

Good Health Capital New York

 
 
China

Gordian Ventures

 
Japan

Goryo Chemical Inc

 
United States

Govig & Associates

 
 
United States

GPG Ventures

 
 
South Korea

gradiant

 
 
Sweden

Gram Equity Invest

 
United States

Grannus Therapeutics

 
 
United States

GreatPoint Ventures

 
Australia

GreenLight Clinical

 
 
Spain

Grifols S.A.

 
United States

GSK

 
 
United States

GSR Ventures

 
United States

GT Biopharma, Inc.

 
United States

Guardian Bio

 
United Kingdom

Gyder Surgical

 
 
United States

H.C. Wainwright

 
 
United States

H.I.G. BioHealth

 
United States

H42, Inc

 
United States

HanchorBio Inc.

 
Ghana

Handprints for Sustainable Development

 
South Korea

Hanmi Pharm

 
United States

Hansoh

 
 
United States

Hanwha Group

 
 
United States

Hanwha Impact Partners

 
 
United States

Harmonix Fund

 
 
United States

HatchBIo Fund/PA Biotechnology Center

 
 
United States

Hatteras Venture Partners

 
United States

Havas

 
United States

Hayim Holding LLC

 
 
Switzerland

HBM Partners AG

 
 
United States

HBS Alumni Angels of Northern California

 
Canada

HDAx Therapeutics

 
Japan

HEALIOS K.K.

 
United States

Healis Therapeutics, Inc

 
 
United States

Health Equity Capital

 
 
United States

Health Innovation Capital

 
United States

HealthBeacon

 
 
United States

Healthcare Angels

 
 
United States

Healthcare Capital Partners

 
 
United States

HealthTech capital

 
 
Singapore

HealthXCapital

 
 
United States

HEDA VENTURES

 
 
United States

Helicase Venture

 
 
United States

Helix Ventures LLC

 
United States

HelloBiome

 
 
United States

Hemisphere Ventures

 
United States

Hemogenyx Pharmaceuticals

 
United States

Henlius

 
Virgin Islands (British)

Hepagene Therapeutics, Inc.

 
Finland

Herantis Pharma Plc

 
 
Singapore

Heritas Capital Management Pte Ltd

 
 
Monaco

Hestia Investments Ltd.

 
 
United States

Hibiscus BioVentures

 
 
United States

HighCape Capital

 
 
Jordan

Hikma Ventures

 
 
United States

Hillhouse Investment

 
United States

Hillstream BioPharma Inc.

 
China

HitGen Inc.

 
 
China

HM Capital

 
Denmark

Hoba Therapeutics

 
United States

Hogan Lovells

 
United States

Homology Medicines

 
 
United States

Hongjing Capital

 
United States

Hopstem Biotechnology

 
 
Australia

Horizon 3 Healthcare

 
 
United States

Horizon Technology Finance Management LLC

 
United States

Houston Methodist Hospital Research Inst.

 
United States

How to Launch an Industry

 
 
Germany

HS LifeSciences GmbH

 
Canada

HTuO Biosciences

 
 
China

Huagai Capital

 
 
China

Huaxing Healthcare Fund

 
China

HuiGene Therapeutics

 
Australia

Humanigen, inc

 
 
United States

Hummingbird Ventures

 
United Kingdom

HungaroTrial CRO

 
 
United States

Hunniwell Lake Ventures

 
United States

HUNUU HEALTH INC.

 
South Korea

HUONS CO.,, LTD.,

 
United States

HUYABIO International

 
United States

Hyloris Pharmaceuticals

 
 
United States

i2020 Accelerator

 
 
United States

i5invest

 
United Kingdom

IAG

 
 
United States

IAG Capital Partners

 
Italy

IAMA Therapeutics

 
United States

IAPP Agency

 
 
United States

Iaso Ventures

 
United States

ICCNC

 
United States

ICON plc

 
South Korea

ICURE PHARMACEUTICAL INC

 
United States

identifeye HEALTH

 
United States

Idience Co., Ltd.

 
United States

IDT Biologika

 
 
Singapore

iGlobe Partners

 
 
United States

Ignite Capital Partners Inc

 
 
United States

Ignite Social Impact

 
United States

iHealthScreen, Inc.

 
France

Iktos

 
South Korea

ILAb Co., Ltd.

 
South Korea

ILDONG Pharmaceutical Co., Ltd

 
South Korea

ILIAS Biologics Inc.

 
United States

Ilios Therapeutics, Inc.

 
 
United States

Illumina Accelerator

 
 
United States

Illumina Ventures

 
United States

ImaginAb Inc

 
Canada

Imeka

 
United States

Immetas Therapeutics

 
United Kingdom

Immodulon Therapeutics Ltd

 
Canada

Immugenia Inc.

 
Canada

Immune Biosolutions

 
United States

Immunis, Inc.

 
Canada

ImmunoBiochem

 
United States

Immunomic Therapeutics, Inc.

 
United States

Immunophotonics, Inc

 
Taiwan, China

Immunwork

 
United States

Immunyx

 
United Kingdom

ImmuPharma plc

 
United States

IMMvention Therapeutix, Inc.

 
 
United States

Impact India Investment Partners, LLC

 
South Korea

IN Therapeutics

 
United States

IN8bio

 
Spain

INBRAIN Neuroelectronics

 
 
China

INCE Capital

 
 
Portugal

Indaco Bio Fund

 
 
Italy

Indaco Venture Partners

 
 
United States

Individual Investor

 
 
Taiwan, China

Industrial Technology Investment Corporation

 
United States

InformAI

 
United States

InGel Therapeutics

 
United States

Inhalon Biopharma, Inc.

 
Denmark

Initiator Pharma

 
United States

Inizio

 
United States

InnDura Therapeutics

 
 
United States

InnoCom Bio Equities, Inc.`

 
Austria

Innophore GmbH

 
 
Singapore

InnoPinnacle Fund

 
Japan

Innovacell K.K.

 
United States

InnovaRegi, LLC

 
United States

Innovation in MedTech

 
 
United States

Innovative Growth Capital Health and Wellness Fund GP Partners LLC

 
United States

Innovo Therapeutics

 
South Korea

Innovotherapeutics

 
 
Germany

INOGROUP

 
United States

Inova

 
 
United States

inovation ventures

 
Denmark

INPROTHER

 
United States

Insider

 
 
United States

Insight Partners

 
Canada

InSilico Medicine

 
United States

Insmed, Inc.

 
Switzerland

InSphero AG

 
Norway

InsuLife AS

 
Switzerland

InterAx Biotech Ltd

 
United States

Interlaken Associates

 
 
United Kingdom

Intermediate Captial Group Life Sceinces

 
Belgium

Intressa Vascular

 
 
Spain

Inveready Asset Management, SGEIC, SA

 
Lithuania

Invest Lithuania

 
 
Canada

Invest Ontario

 
Spain

Investor

 
Austria

invIOs GmbH

 
United States

InvisiShield Technologies, Ltd.

 
France

IOME Bio

 
 
United States

Ion Pacific

 
Switzerland

iOnctura SA

 
United States

IONIQ Sciences

 
 
United States

IP Group North America

 
 
Luxembourg

IPF Partners

 
United States

Ipsen

 
France

iPSirius

 
United States

iQure Pharma Inc

 
Canada

IR&T Imaging Research and Technology

 
United States

Isla Technologies, Inc.

 
United States

Island Pharmaceuticals

 
 
Italy

Italian Angels for Growth

 
Canada

ITR Laboratories Canada Inc.

 
United Kingdom

Ixaka Ltd

 
Japan

J -Pharma Co., Ltd

 
United States

Jaguar Health, Inc.

 
China

Janssen Research & Development, LLC

 
 
United States

JCP Capital

 
 
United States

JDRF T1D Fund

 
 
Switzerland

Jeito Capital

 
Canada

Jenthera Therapeutics

 
United States

Ji Xing Pharmaceuticals

 
China

Jiangsu Protelight Pharma

 
 
United Kingdom

JJDC

 
 
United States

JLS Fund

 
United States

Johns Hopkins Bloomberg School of Public Health

 
 
United States

Johnson & Johnson Innovation

 
 
United States

JonesTrading Institutional Services LLC

 
 
United States

Joyance Partners

 
 
United States

JP Morgan Chase

 
United States

JT Pharma

 
 
India

JT ventures

 
United States

Jubilant Biosys Limited

 
 
United States

Julia Coelho

 
 
United States

Julz Co LLC

 
 
United States

JumpStart Ventures

 
United States

Juno Diagnostics

 
 
United States

Justly Markets

 
United States

Juvena Therapeutics

 
 
United States

K2 HealthVentures

 
United States

Kairos Bioconsulting

 
United States

KalVista Pharmaceuticals

 
South Korea

Kanaph Therapeutics

 
Canada

Kapoose Creek

 
United Kingdom

Kargenera

 
 
Sweden

Karolinska Development AB

 
 
United States

Katan Associates International

 
United States

Kazia Therapeutics Inc

 
 
South Korea

KB Investment

 
United States

KBio

 
United States

KeifeRx

 
 
United States

Keiretsu Forum

 
Iceland

Kerecis

 
United States

Kernal Biologics

 
United States

Keystone Bio, Inc.

 
United States

KHIDI USA

 
 
United States

Khosla Ventures

 
 
United States

Kicker Ventures

 
United States

Kilobaser

 
 
United States

Kineo Finance

 
United States

Kineticos Life Sciences

 
United States

Kinexum

 
 
United States

Kingsford Capital

 
United States

Kintara Therapeutics

 
Canada

KisoJi Biotechnology Inc.

 
 
United States

Kiyoizumi Advisory LLC

 
Puerto Rico

KKH Advisors

 
United States

Knoubis Bio

 
United States

Kolon TissueGene

 
South Korea

Korea Biomedicine Industry Association

 
South Korea

Korea Innovative Medicines Consortium

 
 
United States

Korea Investment Partners

 
 
Spain

Korion Life Sciences

 
Japan

KORTUC Inc.

 
United States

Kowa Research Institute Inc.

 
South Korea

KP Biosciences, Inc.

 
 
China

KP Healthcare Partners

 
 
Canada

KreaMedica Inc.

 
United States

KSK Executive Search

 
 
Germany

Kurma Partners SA

 
United States

Kurome Therapeutics

 
Japan

Kyorin Pharmaceutical Co. Ltd

 
Japan

Kyowa Kirin Co., Ltd.

 
 
United States

Kyto Technology and Life Science

 
United States

Labcorp

 
Spain

Laboratorios Rubio S.A.

 
 
United States

Ladenburg Thalmann

 
United States

Laekna Therapeutics

 
 
United States

Landmark Angels/Family Ofiice

 
Israel

LaserTeam

 
United States

Lassogen

 
United States

Latham BioPharm Group

 
United States

LatticePoint Consulting

 
United States

Latticon Antibody Therapeutics, Inc.

 
Canada

Laurent Pharmaceuticals

 
India

Laurus Labs Ltd.

 
United States

LaVoieHealthScience

 
Netherlands

Lead Pharma

 
United States

Leapfrog Bio

 
United States

LegoChem Biosciences

 
China

Lepu Biopharma

 
United States

Levatio Therapeutics

 
South Korea

LGCHEM

 
 
United States

LI Family Office

 
Netherlands

Liberi Group

 
Spain

Life Length

 
 
United States

Life Science Angels

 
United States

Life Science Cares Bay Area

 
Canada

Life Science Consulting

 
Japan

Life Science Innovation Network Japan

 
United Kingdom

Life Sciences Recruitment

 
 
Spain

LifeLink Ventures

 
 
United States

Lifespan Investments

 
United States

Lifespan.io (Lifespan Extension Advocacy Foundation)

 
United Kingdom

LIfT Biosciences Ltd

 
United States

Lightship Inc.

 
 
Singapore

Lightstone Ventures

 
 
United States

Lilly Asia Ventures

 
United States

Lime Therapeutics

 
 
United States

Lincoln Park Capital LLC

 
 
United States

Lind Partners

 
Australia

Linear Clinical Research

 
China

Lingmed

 
United States

Lipella Pharmaceuticals Inc.

 
United States

Lipocine Inc.

 
 
United States

Lisair

 
United States

Lisata Therapeutics, Inc.

 
United States

List Biotherapeutics

 
 
Canada

Little Green Bamboo

 
United States

LiveCare

 
United States

Livivos Inc

 
United Kingdom

Locate Bio Ltd

 
United States

Logica AI

 
 
Latvia

LongeVC

 
 
United States

Longevity Vision Fund

 
Israel

Lonza

 
United States

Lowenstein Sandler LLP

 
 
China

Loyal Valley Capital

 
 
United States

LSA

 
United States

LSE

 
United States

Lumencor

 
United States

Luminoah

 
 
Canada

Lumira Ventures

 
 
United States

Lunbeck Advisory

 
Italy

Lundbeck Pharmaceuticals italy

 
China

Luoxin Pharmaceutical (Shanghai) Co., Lt

 
United States

Lupin Inc.

 
 
United States

Lyfe Capital

 
 
United States

Lymo Ventures LP

 
 
China

Lynx Capital

 
 
China

LYZZ Capital

 
 
Netherlands

M VENTURES

 
 
United States

M1 Medtech

 
 
United States

M1Medtech

 
United States

MabPlex Inc.

 
United States

MabSwitch Inc

 
Switzerland

Mabylon AG.

 
South Korea

Machaon Biotherapeutics, Inc.

 
 
United States

MagnaSci Venture

 
United States

MAIA Biotechnology, Inc.

 
United States

MaidStone Life Sciences

 
Canada

Mannin Research Inc.

 
 
United States